Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
Epack Durable Ltd leads losers in 'A' group
Jubilant Foodworks Ltd, P I Industries Ltd, JK Lakshmi Cement Ltd and ERIS Lifesciences Ltd are among the other losers in the BSE's 'A' group today, 21 May 2026.
Eris Lifesciences among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks featured in the RSI Trending Up scan on May 20 after gaining over 5%. The RSI moved above the 50 mark from lower levels, signalling improving momentum, strengthening price action, and potential short-term buying opportunities for traders tracking bullish technical setups and momentum-based market trends.
Eris Life Q4 Results: Stock gains 12% as Domestic Branded Formulations leads growth
The management of Eris Lifesciences said the phased rollout of the semaglutide portfolio, including pen-based products and obesity-focused SKUs, is expected to support growth momentum going ahead.
Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1520 in its research report dated February 14, 2026.